SARS-Cov-2 virus Current Affairs, GK & News

Covaxin approved for emergency use in 2–18-year-olds

The Subject Expert Committee on Covid-19 has approved the “emergency use” of Bharat Biotech’s Covaxin vaccine for children aged between 2-18 years old. Key Points Phase-2 and Phase-3 trials of the Covaxin vaccine by Hyderabad-based Bharat Biotech on children below the age of 18 years in the months of September. Trial data was submitted to ..

Month: 

Category: 

Topics: 

EU approves Pfizer-BioNTech COVID vaccine booster

European Medicines Agency (EMA) approved the booster doses of Pfizer/BioNTech Covid-19 vaccine for people aged 18 and above on October 4, 2021. Key Facts This approval given as data for the vaccine showed a rise in antibody levels when a booster shot was administered to the people aged 18 to 55, approximately six months after ..

Month: 

Category: 

Topics: 

WHO Chief Scientist: Covid vaccination is not absolute protection

Chief scientist of World Health Organisation (WHO), Dr. Soumya Swaminathan, noted that though Covid-19 vaccines may not provide absolute protection against emerging variants of the coronavirus. However, it can reduce risks of death and complications. Highlights Dr Swaminathan further emphasised that, people need to be on guard in upcoming months. She noted that, in a ..

Month: 

Category: 

Topics: 

IISc-Mynvax’s heat-tolerant Covid vaccine

Indian Institute of Science (IISc) Bengaluru has developed a heat-tolerant COVID-19 vaccine formulation. While studying on animals, it was found to be effective against all current SARS-CoV-2 variants of concern. Key Points Research was published in ACS Infectious Diseases journal. This vaccine was formulated by IISc-incubated biotech start-up Mynvax, built a strong immune response in ..

Month: 

Category: 

Topics: 

Kappa Covid Variant Detected in Uttar Pradesh

Two cases of highly transmissible Kappa variant of COVID-19 were detected in Uttar Pradesh, recently. Highlights Cases were reported after genome sequencing of samples at Lucknow’s King George medical college. Genome sequencing is a laboratory process which is instrumental for characterising mutations and tracking covid-19 disease outbreaks. Delta Plus variant of COVID-19 was also found ..

Month: 

Category: 

Topics: